Home
GRAL
GRAL News

Latest GRAIL INC (GRAL) News on July 12, 2025

Institutional investors in GRAIL, Inc. (NASDAQ:GRAL) lost 9.3% last week but have reaped the benefits of longer-term growth

Simply Wall St.

17 days ago

Institutional investors in GRAIL, Inc. (NASDAQ:GRAL) lost 9.3% last week but have reaped the benefits of longer-term growth

Grail reports positive outcomes from registrational study of Galleri test

Medical Device Network

23 days ago

Grail reports positive outcomes from registrational study of Galleri test

MT Newswires

24 days ago

Grail Says Galleri Showed Greater Cancer Detection in Pathfinder 2 Study Versus Prior Study; Shares Up

GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study

PR Newswire

24 days ago

GRAIL Announces Positive Top-Line Results From The Galleri® PATHFINDER 2 Registrational Study

Will Tesla have to play catch up to Waymo's robotaxis?

Yahoo Finance Video

a month ago

Will Tesla have to play catch up to Waymo's robotaxis?

Why Scott Bessent wants to make it easier for banks to own Treasurys

Yahoo Finance

a month ago

Why Scott Bessent wants to make it easier for banks to own Treasurys

Statement by Minister Guilbeault on Portuguese Heritage Month

CNW Group

a month ago

Statement by Minister Guilbeault on Portuguese Heritage Month

Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population

PR Newswire

a month ago

Thyme Care Triples Its Multidisciplinary Care Team with Increased Focus on Often-Overlooked Survivorship Population

GlobeNewswire

a month ago

Replimune Presents New Analyses from the IGNYTE Study of RP1 plus Nivolumab in Anti-PD1 Failed Melanoma at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry

GlobeNewswire

a month ago

EKOUAER Launches Wedding Season Special Edition and Joins The Knot Registry

Man Utd sign Brazil forward Cunha from Wolves

AFP

a month ago

Man Utd sign Brazil forward Cunha from Wolves

‘All the crypto cowboys are gone’: Kevin O’Leary says the sector is safe now and is backing stablecoins

Moneywise

a month ago

‘All the crypto cowboys are gone’: Kevin O’Leary says the sector is safe now and is backing stablecoins

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire

a month ago

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GRAIL to Present at Jefferies Global Healthcare Conference 2025

PR Newswire

2 months ago

GRAIL to Present at Jefferies Global Healthcare Conference 2025

GRAIL First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

2 months ago

GRAIL First Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag

Thomson Reuters StreetEvents

2 months ago

Q1 2025 Grail Inc Earnings Call

Grail partners with athenahealth for MCED test ordering

Medical Device Network

2 months ago

Grail partners with athenahealth for MCED test ordering

GuruFocus.com

2 months ago

GRAIL Inc (GRAL) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances

GRAIL Reports First Quarter 2025 Financial Results

PR Newswire

2 months ago

GRAIL Reports First Quarter 2025 Financial Results

GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test

PR Newswire

2 months ago

GRAIL and athenahealth Team Up to Offer Healthcare Providers Streamlined Ordering of GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test

MT Newswires

2 months ago

Grail Insider Sold Shares Worth $1,396,220, According to a Recent SEC Filing

MT Newswires

2 months ago

Grail Insider Sold Shares Worth $1,635,867, According to a Recent SEC Filing

Why GRAIL, Inc. (GRAL) is Surging in 2025

Insider Monkey

2 months ago

Why GRAIL, Inc. (GRAL) is Surging in 2025

GRAIL to Announce First Quarter 2025 Financial Results

PR Newswire

2 months ago

GRAIL to Announce First Quarter 2025 Financial Results

GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting

PR Newswire

3 months ago

GRAIL to Present New Data on Galleri® and its Methylation Platform at American Association for Cancer Research (AACR) Annual Meeting

This Cancer Test Could Become Routine—and a Big Seller, Says Analyst

Barrons.com

3 months ago

This Cancer Test Could Become Routine—and a Big Seller, Says Analyst

GRAIL, Inc. (GRAL): A Bull Case Theory

Insider Monkey

3 months ago

GRAIL, Inc. (GRAL): A Bull Case Theory

Jim Cramer Likes GRAIL, Inc. (GRAL) Despite Losses – Great Science, Risky Bet!

Insider Monkey

3 months ago

Jim Cramer Likes GRAIL, Inc. (GRAL) Despite Losses – Great Science, Risky Bet!

Is GRAIL, Inc. (GRAL) Among Jeff Bezos’ Investments in 2025?

Insider Monkey

4 months ago

Is GRAIL, Inc. (GRAL) Among Jeff Bezos’ Investments in 2025?

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire

5 months ago

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing

PR Newswire

5 months ago

GRAIL Partners With Actress Kate Walsh for Generation Possible to Raise Awareness of Multi-Cancer Early Detection Testing

GRAIL, Inc. (GRAL): Among the Best Performing Small Cap Stocks So Far In 2025

Insider Monkey

5 months ago

GRAIL, Inc. (GRAL): Among the Best Performing Small Cap Stocks So Far In 2025

Why Grail (GRAL) Is Falling Today

Insider Monkey

5 months ago

Why Grail (GRAL) Is Falling Today

GRAIL to Present at TD Cowen 45th Annual Health Care Conference

PR Newswire

5 months ago

GRAIL to Present at TD Cowen 45th Annual Health Care Conference

GuruFocus.com

5 months ago

GRAIL Inc (GRAL) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic Partnerships ...

GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results

PR Newswire

5 months ago

GRAIL Reports Fourth Quarter and Full Year 2024 Financial Results

We're Keeping An Eye On GRAIL's (NASDAQ:GRAL) Cash Burn Rate

Simply Wall St.

5 months ago

We're Keeping An Eye On GRAIL's (NASDAQ:GRAL) Cash Burn Rate

GRAIL to Announce Fourth Quarter 2024 Financial Results

PR Newswire

5 months ago

GRAIL to Announce Fourth Quarter 2024 Financial Results

Why Grail (GRAL) Stock Is Jumping Today

Insider Monkey

5 months ago

Why Grail (GRAL) Stock Is Jumping Today

MT Newswires

5 months ago

Grail Makes Cancer Early Detection Test Directly Available to US Physicians Via Quest Diagnostics Collaboration

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

PR Newswire

5 months ago

GRAIL and Quest Diagnostics Provide GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test Through the Quest Diagnostics Test Ordering System

Watch These Grail Price Levels After Med Tech Company's Stock Soared 64% Last Week

Investopedia

6 months ago

Watch These Grail Price Levels After Med Tech Company's Stock Soared 64% Last Week

Why Grail (GRAL) Is Rallying for a Second Straight Day

Insider Monkey

6 months ago

Why Grail (GRAL) Is Rallying for a Second Straight Day

Early Cancer Detection Firm Grail Leads Nasdaq Gainers as Stock Jumps 20%

Investopedia

6 months ago

Early Cancer Detection Firm Grail Leads Nasdaq Gainers as Stock Jumps 20%

MT Newswires

6 months ago

Grail's 2024 Revenue Guidance Beats Analyst Estimates

Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology

PR Newswire

6 months ago

Patient Reported Outcomes for GRAIL's Galleri® Multi-Cancer Early Detection Blood Test Published in Lancet Oncology

Disappointing week for GRAIL, Inc. (NASDAQ:GRAL) institutional investors who control 48% of the company

Simply Wall St.

7 months ago

Disappointing week for GRAIL, Inc. (NASDAQ:GRAL) institutional investors who control 48% of the company

GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference

PR Newswire

7 months ago

GRAIL to Present at the 43rd Annual J.P. Morgan Healthcare Conference

What's Going On With Illumina Stock On Monday?

Benzinga

7 months ago

What's Going On With Illumina Stock On Monday?

One Of IBD's Best Screens Identifies These Four Market Leaders, Including Garmin, Ollie's

Investor's Business Daily

7 months ago

One Of IBD's Best Screens Identifies These Four Market Leaders, Including Garmin, Ollie's

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire

7 months ago

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

MT Newswires

7 months ago

Grail 1st-Mover Advantage Faces Regulatory Hurdles in Multi-Cancer Detection, Morgan Stanley Says

MT Newswires

8 months ago

Grail Insider Sold Shares Worth $426,937, According to a Recent SEC Filing

GRAIL to Participate in Upcoming Investor Conferences

PR Newswire

8 months ago

GRAIL to Participate in Upcoming Investor Conferences

MT Newswires

8 months ago

GRAIL Says First Person Tested With Blood-Based Assay in Lung Cancer Trial

GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study

PR Newswire

8 months ago

GRAIL Announces First Patient Tested With Blood-Based Assay in Global Phase 3 Adjuvant Lung Cancer Study

Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now?

Insider Monkey

8 months ago

Is Illumina, Inc. (ILMN) the Best Immunotherapy Stock to Buy Now?

GuruFocus.com

8 months ago

GRAIL Inc (GRAL) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amidst Strategic ...

GRAIL Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

8 months ago

GRAIL Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

GRAIL Reports Third Quarter 2024 Financial Results

PR Newswire

8 months ago

GRAIL Reports Third Quarter 2024 Financial Results

GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

PR Newswire

8 months ago

GRAIL to Present at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

GRAIL to Announce Third Quarter 2024 Financial Results

PR Newswire

8 months ago

GRAIL to Announce Third Quarter 2024 Financial Results

GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference

PR Newswire

9 months ago

GRAIL Presents Initial Results From REFLECTION Real-World Evidence Study of Galleri® Multi-Cancer Early Detection (MCED) Test at the Early Detection of Cancer Conference

GRAIL Appoints Sarah Krevans to Board of Directors

PR Newswire

9 months ago

GRAIL Appoints Sarah Krevans to Board of Directors

Argus Research

9 months ago

Daily – Vickers Top Buyers & Sellers for 10/18/2024

GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now

Insider Monkey

9 months ago

GRAIL, Inc. (GRAL): Jeff Bezos Is Buying This Stock Now

CRCM LP's Strategic Acquisition of GRAIL Inc Shares

GuruFocus.com

9 months ago

CRCM LP's Strategic Acquisition of GRAIL Inc Shares

We're Keeping An Eye On GRAIL's (NASDAQ:GRAL) Cash Burn Rate

Simply Wall St.

10 months ago

We're Keeping An Eye On GRAIL's (NASDAQ:GRAL) Cash Burn Rate

Illumina Wins Court Fight With EU Over $7 Billion Grail Deal

Bloomberg

10 months ago

Illumina Wins Court Fight With EU Over $7 Billion Grail Deal

MT Newswires

10 months ago

Illumina Wins Jurisdictional Appeal in Europe Over GRAIL Acquisition

GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)

PR Newswire

10 months ago

GRAIL ANNOUNCES INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(c)(4)

Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology

PR Newswire

10 months ago

Results of GRAIL's Galleri® Multi-Cancer Early Detection Blood Test in Prostate Cancer Published in JCO Precision Oncology

MT Newswires

a year ago

Grail Insider Sold Shares Worth $1,203,650, According to a Recent SEC Filing

MT Newswires

a year ago

Grail Insider Sold Shares Worth $254,121, According to a Recent SEC Filing

GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

PR Newswire

a year ago

GRAIL to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference

Grail to shed 350 workers in restructuring

MedTech Dive

a year ago

Grail to shed 350 workers in restructuring

MT Newswires

a year ago

Grail Q2 Net Loss Widens, Revenue Rises; Cost Cuts Planned; Shares Jump After Hours

GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update

PR Newswire

a year ago

GRAIL Reports Second Quarter 2024 Financial Results and Provides a Strategic Update

Wheels Up Announces Gregory Summe to Join Board of Directors

PR Newswire

a year ago

Wheels Up Announces Gregory Summe to Join Board of Directors

GRAIL to Announce Second Quarter 2024 Financial Results

PR Newswire

a year ago

GRAIL to Announce Second Quarter 2024 Financial Results

Here’s Why You Should Add Illumina (ILMN) to Your Portfolio

Insider Monkey

a year ago

Here’s Why You Should Add Illumina (ILMN) to Your Portfolio

Grail announces first patients enrolled in REACH cancer trial

Medical Device Network

a year ago

Grail announces first patients enrolled in REACH cancer trial

GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (MCED) Test in the Medicare Population

PR Newswire

a year ago

GRAIL Announces First Participant Enrolled in REACH Study Evaluating Clinical Impact of Galleri® Multi-Cancer Early Detection (MCED) Test in the Medicare Population

MT Newswires

a year ago

Sector Update: Health Care Stocks Edge Higher Premarket Monday

MT Newswires

a year ago

Grail Completes Enrollment in US Study for Cancer Early-Detection Device

GRAIL Advances the Galleri® Registrational Clinical Trial Program

PR Newswire

a year ago

GRAIL Advances the Galleri® Registrational Clinical Trial Program

Share on Social Networks: